ByNobleID
    EFFECTS OF INTERMITTENT INTRAVENOUS OR ORAL DAILY 1,25(OH)2D3 WERE GIVEN BY SAME DOSE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYRODISM | NobleID